| miRNA | gene name | experiments | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| hsa-miR-205-5p | LRP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | ZEB1 |
|
||||||||||||||||||
| hsa-miR-205-5p | MED1 |
|
||||||||||||||||||
| hsa-miR-205-5p | E2F5 |
|
||||||||||||||||||
| hsa-miR-205-5p | E2F1 |
|
||||||||||||||||||
| hsa-miR-205-5p | ERBB3 |
|
||||||||||||||||||
| hsa-miR-205-5p | ZEB2 |
|
||||||||||||||||||
| hsa-miR-205-5p | PRKCE |
|
||||||||||||||||||
| hsa-miR-205-5p | IL24 |
|
||||||||||||||||||
| hsa-miR-205-5p | IL32 |
|
||||||||||||||||||
| hsa-miR-205-5p | EGLN2 |
|
||||||||||||||||||
| hsa-miR-205-5p | TP73 |
|
||||||||||||||||||
| hsa-miR-205-5p | CYR61 |
|
||||||||||||||||||
| hsa-miR-205-5p | CTGF |
|
||||||||||||||||||
| hsa-miR-205-5p | ERBB2 |
|
||||||||||||||||||
| hsa-miR-205-5p | LAMC1 |
|
||||||||||||||||||
| hsa-miR-205-5p | LRRK2 |
|
||||||||||||||||||
| hsa-miR-205-5p | YES1 |
|
||||||||||||||||||
| hsa-miR-205-5p | SRC |
|
||||||||||||||||||
| hsa-miR-205-5p | BCL2 |
|
||||||||||||||||||
| hsa-miR-205-5p | SMAD1 |
|
||||||||||||||||||
| hsa-miR-205-5p | SMAD4 |
|
||||||||||||||||||
| hsa-miR-205-5p | YY1 |
|
||||||||||||||||||
| hsa-miR-205-5p | PTPRM |
|
||||||||||||||||||
| hsa-miR-205-5p | AR |
|
||||||||||||||||||
| hsa-miR-205-5p | BCL6 |
|
||||||||||||||||||
| hsa-miR-205-5p | ACSL4 |
|
||||||||||||||||||
| hsa-miR-205-5p | ITGA5 |
|
||||||||||||||||||
| hsa-miR-205-5p | ACSL1 |
|
||||||||||||||||||
| hsa-miR-205-5p | STK38L |
|
||||||||||||||||||
| hsa-miR-205-5p | NUFIP2 |
|
||||||||||||||||||
| hsa-miR-205-5p | PTPRJ |
|
||||||||||||||||||
| hsa-miR-205-5p | XPR1 |
|
||||||||||||||||||
| hsa-miR-205-5p | ETNK1 |
|
||||||||||||||||||
| hsa-miR-205-5p | DMXL2 |
|
||||||||||||||||||
| hsa-miR-205-5p | NSF |
|
||||||||||||||||||
| hsa-miR-205-5p | UBE2Z |
|
||||||||||||||||||
| hsa-miR-205-5p | GNAS |
|
||||||||||||||||||
| hsa-miR-205-5p | SQLE |
|
||||||||||||||||||
| hsa-miR-205-5p | CPEB3 |
|
||||||||||||||||||
| hsa-miR-205-5p | ETF1 |
|
||||||||||||||||||
| hsa-miR-205-5p | ZNF585B |
|
||||||||||||||||||
| hsa-miR-205-5p | HMGB3 |
|
||||||||||||||||||
| hsa-miR-205-5p | PTEN |
|
||||||||||||||||||
| hsa-miR-205-5p | ESRRG |
|
||||||||||||||||||
| hsa-miR-205-5p | PHLPP2 |
|
||||||||||||||||||
| hsa-miR-205-5p | KCNJ10 |
|
||||||||||||||||||
| hsa-miR-205-5p | YEATS2 |
|
||||||||||||||||||
| hsa-miR-205-5p | VAMP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | TOLLIP |
|
||||||||||||||||||
| hsa-miR-205-5p | TMEM55B |
|
||||||||||||||||||
| hsa-miR-205-5p | TMEM123 |
|
||||||||||||||||||
| hsa-miR-205-5p | TAF11 |
|
||||||||||||||||||
| hsa-miR-205-5p | SERTAD2 |
|
||||||||||||||||||
| hsa-miR-205-5p | RTN3 |
|
||||||||||||||||||
| hsa-miR-205-5p | RFX7 |
|
||||||||||||||||||
| hsa-miR-205-5p | RAP2B |
|
||||||||||||||||||
| hsa-miR-205-5p | PLAGL2 |
|
||||||||||||||||||
| hsa-miR-205-5p | PICALM |
|
||||||||||||||||||
| hsa-miR-205-5p | PHC2 |
|
||||||||||||||||||
| hsa-miR-205-5p | PARD6B |
|
||||||||||||||||||
| hsa-miR-205-5p | PANK1 |
|
||||||||||||||||||
| hsa-miR-205-5p | NOTCH2 |
|
||||||||||||||||||
| hsa-miR-205-5p | NIPA2 |
|
||||||||||||||||||
| hsa-miR-205-5p | NDUFB2 |
|
||||||||||||||||||
| hsa-miR-205-5p | NDUFA4 |
|
||||||||||||||||||
| hsa-miR-205-5p | MMD |
|
||||||||||||||||||
| hsa-miR-205-5p | MGLL |
|
||||||||||||||||||
| hsa-miR-205-5p | MED13 |
|
||||||||||||||||||
| hsa-miR-205-5p | MARCKS |
|
||||||||||||||||||
| hsa-miR-205-5p | LYSMD3 |
|
||||||||||||||||||
| hsa-miR-205-5p | LYN |
|
||||||||||||||||||
| hsa-miR-205-5p | LRRC59 |
|
||||||||||||||||||
| hsa-miR-205-5p | LPCAT1 |
|
||||||||||||||||||
| hsa-miR-205-5p | IPO7 |
|
||||||||||||||||||
| hsa-miR-205-5p | SARAF |
|
||||||||||||||||||
| hsa-miR-205-5p | EZR |
|
||||||||||||||||||
| hsa-miR-205-5p | ENPP4 |
|
||||||||||||||||||
| hsa-miR-205-5p | CUL5 |
|
||||||||||||||||||
| hsa-miR-205-5p | CLIP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | CDKN2AIPNL |
|
||||||||||||||||||
| hsa-miR-205-5p | CDK6 |
|
||||||||||||||||||
| hsa-miR-205-5p | GUCD1 |
|
||||||||||||||||||
| hsa-miR-205-5p | C1orf123 |
|
||||||||||||||||||
| hsa-miR-205-5p | B4GALT6 |
|
||||||||||||||||||
| hsa-miR-205-5p | B4GALT5 |
|
||||||||||||||||||
| hsa-miR-205-5p | AFF4 |
|
||||||||||||||||||
| hsa-miR-205-5p | AFF1 |
|
||||||||||||||||||
| hsa-miR-205-5p | TEX35 |
|
||||||||||||||||||
| hsa-miR-205-5p | SMIM13 |
|
||||||||||||||||||
| hsa-miR-205-5p | SERINC3 |
|
||||||||||||||||||
| hsa-miR-205-5p | RNF217 |
|
||||||||||||||||||
| hsa-miR-205-5p | NFAT5 |
|
||||||||||||||||||
| hsa-miR-205-5p | LCOR |
|
||||||||||||||||||
| hsa-miR-205-5p | NPRL3 |
|
||||||||||||||||||
| hsa-miR-205-5p | ACTRT3 |
|
||||||||||||||||||
| hsa-miR-205-5p | GOT1 |
|
||||||||||||||||||
| hsa-miR-205-5p | F2RL2 |
|
||||||||||||||||||
| hsa-miR-205-5p | DHCR24 |
|
||||||||||||||||||
| hsa-miR-205-5p | EID2B |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC38A1 |
|
||||||||||||||||||
| hsa-miR-205-5p | RAB11FIP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | C11orf74 |
|
||||||||||||||||||
| hsa-miR-205-5p | DNAJA1 |
|
||||||||||||||||||
| hsa-miR-205-5p | LRRTM4 |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC39A14 |
|
||||||||||||||||||
| hsa-miR-205-5p | BDP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | TRAF3IP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | ICK |
|
||||||||||||||||||
| hsa-miR-205-5p | PRLR |
|
||||||||||||||||||
| hsa-miR-205-5p | BORCS5 |
|
||||||||||||||||||
| hsa-miR-205-5p | ACP1 |
|
||||||||||||||||||
| hsa-miR-205-5p | PHF12 |
|
||||||||||||||||||
| hsa-miR-205-5p | MAP3K9 |
|
||||||||||||||||||
| hsa-miR-205-5p | MAML2 |
|
||||||||||||||||||
| hsa-miR-205-5p | AMOT |
|
||||||||||||||||||
| hsa-miR-205-5p | HOXA11 |
|
||||||||||||||||||
| hsa-miR-205-5p | IMPAD1 |
|
||||||||||||||||||
| hsa-miR-205-5p | TCF20 |
|
||||||||||||||||||
| hsa-miR-205-5p | PRR15 |
|
||||||||||||||||||
| hsa-miR-205-5p | PAPPA-AS1 |
|
||||||||||||||||||
| hsa-miR-205-5p | CFAP65 |
|
||||||||||||||||||
| hsa-miR-205-5p | PRRG4 |
|
||||||||||||||||||
| hsa-miR-205-5p | BCL9L |
|
||||||||||||||||||
| hsa-miR-205-5p | SHISA6 |
|
||||||||||||||||||
| hsa-miR-205-5p | JMJD1C |
|
||||||||||||||||||
| hsa-miR-205-5p | SMNDC1 |
|
||||||||||||||||||
| hsa-miR-205-5p | PLCXD2 |
|
||||||||||||||||||
| hsa-miR-205-5p | ANGPTL7 |
|
||||||||||||||||||
| hsa-miR-205-5p | SRD5A1 |
|
||||||||||||||||||
| hsa-miR-205-5p | TNFSF8 |
|
||||||||||||||||||
| hsa-miR-205-5p | VPS52 |
|
||||||||||||||||||
| hsa-miR-205-5p | TMEM239 |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC7A2 |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC41A1 |
|
||||||||||||||||||
| hsa-miR-205-5p | RBBP4 |
|
||||||||||||||||||
| hsa-miR-205-5p | PAIP2B |
|
||||||||||||||||||
| hsa-miR-205-5p | NOX5 |
|
||||||||||||||||||
| hsa-miR-205-5p | NEK9 |
|
||||||||||||||||||
| hsa-miR-205-5p | MRPL44 |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC25A25 |
|
||||||||||||||||||
| hsa-miR-205-5p | CREB1 |
|
||||||||||||||||||
| hsa-miR-205-5p | CDK1 |
|
||||||||||||||||||
| hsa-miR-205-5p | RAN |
|
||||||||||||||||||
| hsa-miR-205-5p | BAMBI |
|
||||||||||||||||||
| hsa-miR-205-5p | KCTD16 |
|
||||||||||||||||||
| hsa-miR-205-5p | TMSB4X |
|
||||||||||||||||||
| hsa-miR-205-5p | GM2A |
|
||||||||||||||||||
| hsa-miR-205-5p | TMEM201 |
|
||||||||||||||||||
| hsa-miR-205-5p | PHF8 |
|
||||||||||||||||||
| hsa-miR-205-5p | TM9SF2 |
|
||||||||||||||||||
| hsa-miR-205-5p | YWHAH |
|
||||||||||||||||||
| hsa-miR-205-5p | SPDL1 |
|
||||||||||||||||||
| hsa-miR-205-5p | MAPK14 |
|
||||||||||||||||||
| hsa-miR-205-5p | TXNL1 |
|
||||||||||||||||||
| hsa-miR-205-5p | RGS6 |
|
||||||||||||||||||
| hsa-miR-205-5p | KCTD20 |
|
||||||||||||||||||
| hsa-miR-205-5p | XPOT |
|
||||||||||||||||||
| hsa-miR-205-5p | SLC5A12 |
|
||||||||||||||||||
| hsa-miR-205-5p | VTI1A |
|
||||||||||||||||||
| hsa-miR-205-5p | C6orf201 |
|
||||||||||||||||||
| hsa-miR-205-5p | NUDT21 |
|
||||||||||||||||||
| hsa-miR-205-5p | KLHL5 |
|
||||||||||||||||||
| hsa-miR-205-5p | NCAPG |
|
| authors | journal | year | Pubmed link | title | |
|---|---|---|---|---|---|
| 1 | Song et al. | Biochem. Biophys. Res. Commun. | 2009 | 19665999 | MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1. |
| 2 | Hurteau et al. | Cell Cycle | 2009 | 19502803 | Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. |
| 3 | Gregory et al. | Nat. Cell Biol. | 2008 | 18376396 | The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
| 4 | Lee et al. | Oncogene | 2014 | 23474752 | Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. |
| 5 | Gandellini et al. | Cell Death Differ. | 2012 | 22555458 | miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. |
| 6 | Riley et al. | EMBO J. | 2012 | 22473208 | EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. |
| 7 | Hulf et al. | Oncogene | 2013 | 22869146 | Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer. |
| 8 | Mouillet et al. | FASEB J. | 2010 | 20065103 | MiR-205 silences MED1 in hypoxic primary human trophoblasts. |
| 9 | Dar et al. | J. Biol. Chem. | 2011 | 21454583 | miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. |
| 10 | Piovan et al. | Mol Oncol | 2012 | 22578566 | Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. |
| 11 | Noguchi et al. | Mol. Ther. | 2013 | 23629002 | Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo. |
| 12 | Wang et al. | Cell Death Dis | 2013 | 23519125 | Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells. |
| 13 | Iorio et al. | Cancer Res. | 2009 | 19276373 | microRNA-205 regulates HER3 in human breast cancer. |
| 14 | Barker et al. | Curr Opin Pharmacol | 2010 | 20864407 | Regulation of ErbB receptor signalling in cancer cells by microRNA. |
| 15 | Wu et al. | Cell Res. | 2009 | 19238171 | Suppression of cell growth and invasion by miR-205 in breast cancer. |
| 16 | Gandellini et al. | Cancer Res. | 2009 | 19244118 | miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. |
| 17 | Majid et al. | Cancer | 2010 | 20737563 | MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. |
| 18 | Kim et al. | Mol. Cells | 2013 | 23212344 | MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells. |
| 19 | Muratsu-Ikeda et al. | PLoS ONE | 2012 | 22859986 | Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. |
| 20 | Alla et al. | Cell Cycle | 2012 | 22871739 | E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry. |
| 21 | Xie et al. | PLoS ONE | 2012 | 23056551 | miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. |
| 22 | Adachi et al. | Biochem. Biophys. Res. Commun. | 2011 | 21787752 | ErbB2 down-regulates microRNA-205 in breast cancer. |
| 23 | Cho et al. | Hum. Mol. Genet. | 2013 | 23125283 | MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. |
| 24 | Majid et al. | Cancer Res. | 2011 | 21330408 | MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. |
| 25 | Lipchina et al. | Genes Dev. | 2011 | 22012620 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. |
| 26 | Tian et al. | Med. Oncol. | 2014 | 24297308 | MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma. |
| 27 | Verdoodt et al. | Int. J. Oncol. | 2013 | 23612742 | MicroRNA-205, a novel regulator of the anti-apoptotic protein Bcl2, is downregulated in prostate cancer. |
| 28 | Tabruyn et al. | Angiogenesis | 2013 | 23800974 | MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. |
| 29 | Yin et al. | Eur Rev Med Pharmacol Sci | 2014 | 24763883 | Down-regulation of microRNA-205 promotes gastric cancer cell proliferation. |
| 30 | Luo et al. | J Transl Med | 2013 | 23497265 | A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells. |
| 31 | Hagman et al. | Br. J. Cancer | 2013 | 23571738 | miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. |
| 32 | Karginov et al. | Genes Dev. | 2013 | 23824327 | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. |
| 33 | Motsch et al. | PLoS ONE | 2012 | 22870299 | MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. |
| 34 | Cui et al. | Biochem. Biophys. Res. Commun. | 2014 | 24576478 | Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4. |
| 35 | Larzabal et al. | Br. J. Cancer | 2014 | 24434435 | TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. |
| 36 | Cui et al. | Biochem. Biophys. Res. Commun. | 2014 | 24462768 | MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. |
| 37 | Xue et al. | Cell | 2013 | 23313552 | Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. |
| 38 | Memczak et al. | Nature | 2013 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. |
| 39 | Whisnant et al. | MBio | 2013 | 23592263 | In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. |
| 40 | Kishore et al. | Nat. Methods | 2011 | 21572407 | A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. |
| 41 | Elgamal et al. | PLoS ONE | 2013 | 24098490 | Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. |
| 42 | Lei et al. | Oncol. Rep. | 2013 | 24084898 | miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. |
| 43 | Wang et al. | Oncol. Rep. | 2013 | 23564023 | SZ-685C exhibits potent anticancer activity in both radiosensitive and radioresistant NPC cells through the miR-205-PTEN-Akt pathway. |
| 44 | Cai et al. | Cancer Res. | 2013 | 23856247 | miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. |
| 45 | Su et al. | Oncol. Rep. | 2013 | 23589079 | miR-205 promotes tumor proliferation and invasion through targeting ESRRG in endometrial carcinoma. |
| 46 | Lin et al. | Invest. Ophthalmol. Vis. Sci. | 2013 | 23950153 | Inhibition of miR-205 impairs the wound-healing process in human corneal epithelial cells by targeting KIR4.1 (KCNJ10). |
| 47 | Gottwein et al. | Cell Host Microbe | 2011 | 22100165 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. |
| 48 | Hafner et al. | Cell | 2010 | 20371350 | Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. |
| 49 | Farazi et al. | Genome Biol. | 2014 | 24398324 | Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. |
| 50 | Chi et al. | Nature | 2009 | 19536157 | Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. |
| 51 | Majoros et al. | Nat. Methods | 2013 | 23708386 | MicroRNA target site identification by integrating sequence and binding information. |
| 52 | Skalsky et al. | PLoS Pathog. | 2012 | 22291592 | The viral and cellular microRNA targetome in lymphoblastoid cell lines. |